NEW YORK, Jan. 5 (GenomeWeb News) - Shares in Affymetrix were up 6.95 percent at $36.30 in late-afternoon trading after the company said sales during the fourth quarter of 2004 increased 17 percent to more than $100 million.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.